Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38149 |
β-Amyloid (1-43)(human)
|
||
The amyloid β-protein is a 39- to 43-amino acid polypeptide that is the primary constituent of senile plaques and cerebrovascular deposits in Alzheimer's disease and Down's syndrome. Additionally it acts as an inhibitor of the ubiquitin-dependent protein degradation in vitro. | |||
TP1719 |
β-Amyloid (33-40)
β-Amyloid 33-40 |
||
β-Amyloid (33-40) is a peptide consisting of amino acid of 33 to 40 of beta amyloid protein. | |||
TP1500 |
β-Amyloid (1-17)
β-Amyloid 1-17 |
||
This synthetic peptide consists of amino acids 1 to 17 of beta amyloid protein. This peptide can be employed in beta amyloid solubility studies. | |||
TP1673 |
β-Amyloid (11-22)
β-Amyloid 11-22 |
||
β-Amyloid (11-22) is a peptide fragment of β-Amyloid.Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer’s patients, is thought to be the cause of Alzheimer’s Disease (AD). AD is the most common neurodegenerat |